Yulan Li

1.5k total citations · 2 hit papers
60 papers, 964 citations indexed

About

Yulan Li is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Yulan Li has authored 60 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Reproductive Medicine, 16 papers in Obstetrics and Gynecology and 6 papers in Surgery. Recurrent topics in Yulan Li's work include Uterine Myomas and Treatments (16 papers), Endometriosis Research and Treatment (15 papers) and Gynecological conditions and treatments (10 papers). Yulan Li is often cited by papers focused on Uterine Myomas and Treatments (16 papers), Endometriosis Research and Treatment (15 papers) and Gynecological conditions and treatments (10 papers). Yulan Li collaborates with scholars based in China, United States and Italy. Yulan Li's co-authors include Nathalie Cretin, Jacques Dantal, Š Vı́tko, Raimund Margreiter, Willem Weimar, Rachel B. Wagman, Juan Camilo Arjona Ferreira, Roberta Venturella, Andrea S. Lukes and Ayman Al‐Hendy and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Yulan Li

56 papers receiving 919 citations

Hit Papers

Treatment of Uterine Fibroid Symptoms with Relugolix Comb... 2021 2026 2022 2024 2021 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yulan Li China 12 420 304 277 267 115 60 964
Daniel Murillo United States 15 249 0.6× 156 0.5× 28 0.1× 45 0.2× 36 0.3× 30 541
Mireía Musquera Spain 21 354 0.8× 497 1.6× 14 0.1× 68 0.3× 56 0.5× 114 1.4k
Andrea G. Kattah United States 19 66 0.2× 65 0.2× 27 0.1× 364 1.4× 22 0.2× 75 1.2k
Raj Thuraisingham United Kingdom 20 241 0.6× 298 1.0× 5 0.0× 112 0.4× 44 0.4× 50 1.1k
Madison C. Cuffy United States 18 247 0.6× 439 1.4× 17 0.1× 16 0.1× 29 0.3× 42 899
Sônia K. Nishida Brazil 17 74 0.2× 82 0.3× 12 0.0× 69 0.3× 21 0.2× 42 669
Philip McShane United Kingdom 14 202 0.5× 782 2.6× 9 0.0× 35 0.1× 25 0.2× 18 1.1k
Hao‐Chung Ho Taiwan 15 78 0.2× 311 1.0× 8 0.0× 31 0.1× 169 1.5× 74 828
Vimal Patel Canada 17 26 0.1× 197 0.6× 52 0.2× 40 0.1× 15 0.1× 54 872
Ramcharan Thiagarajan United States 18 487 1.2× 639 2.1× 10 0.0× 12 0.0× 84 0.7× 31 1.2k

Countries citing papers authored by Yulan Li

Since Specialization
Citations

This map shows the geographic impact of Yulan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulan Li more than expected).

Fields of papers citing papers by Yulan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulan Li. The network helps show where Yulan Li may publish in the future.

Co-authorship network of co-authors of Yulan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yulan Li. A scholar is included among the top collaborators of Yulan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulan Li. Yulan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Jiahao, et al.. (2025). Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis. Frontiers in Immunology. 16. 1560589–1560589.
2.
Luo, Sheng, Wenjun Zhang, Lei Liu, et al.. (2025). De novo TANC2 variants caused developmental and epileptic encephalopathy and epilepsy. Epilepsia. 66(7). 2365–2378. 3 indexed citations
4.
Liu, Qian, et al.. (2024). Fighting ferroptosis: Protective effects of dexmedetomidine on vital organ injuries. Life Sciences. 354. 122949–122949. 1 indexed citations
5.
6.
Huang, Rongrong, et al.. (2024). FAM134B deletion exacerbates apoptosis and epithelial-to-mesenchymal transition in rat lungs exposed to hyperoxia. iScience. 27(7). 110385–110385. 2 indexed citations
7.
Al‐Hendy, Ayman, Andrea S. Lukes, Alfred N. Poindexter, et al.. (2023). A Plain Language Summary of the Safety of Relugolix Combination Therapy and Improvement in Symptoms in Women with Uterine Fibroids from the LIBERTY 1 and LIBERTY 2 Studies. Pain Management. 13(4). 205–211. 1 indexed citations
8.
Stewart, Elizabeth A., Andrea S. Lukes, Roberta Venturella, et al.. (2022). Relugolix Combination Therapy for Uterine Leiomyoma–Associated Pain in the LIBERTY Randomized Trials. Obstetrics and Gynecology. 139(6). 1070–1081. 13 indexed citations
9.
Al‐Hendy, Ayman, Andrea S. Lukes, Alfred N. Poindexter, et al.. (2022). Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas. Obstetrics and Gynecology. 140(6). 920–930. 24 indexed citations
10.
Al‐Hendy, Ayman, Andrea S. Lukes, Alfred N. Poindexter, et al.. (2021). Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy. New England Journal of Medicine. 384(7). 630–642. 122 indexed citations breakdown →
11.
Al‐Hendy, Ayman, Andrea S. Lukes, Alfred N. Poindexter, et al.. (2021). Treatment of Uterine Fibroid Symptoms With Relugolix Combination Therapy. Obstetrical & Gynecological Survey. 76(6). 334–336. 2 indexed citations
12.
Wang, Xiaoxia, et al.. (2020). Lung injury induced by short-term mechanical ventilation with hyperoxia and its mitigation by deferoxamine in rats. BMC Anesthesiology. 20(1). 18 indexed citations
13.
As‐Sanie, Sawsan, Christian M. Becker, Neil Johnson, et al.. (2020). EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (SPIRIT 2). Fertility and Sterility. 114(3). e77–e77. 8 indexed citations
14.
Al‐Hendy, Ayman, Andrea S. Lukes, Roberta Venturella, et al.. (2020). RELUGOLIX COMBINATION THERAPY IMPROVES UTERINE FIBROID-ASSOCIATED PAIN DURING MENSTRUAL AND NON-MENSTRUAL DAYS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM. Fertility and Sterility. 114(3). e232–e232. 1 indexed citations
15.
Liang, Xi, et al.. (2020). Electroacupuncture pretreatment alleviates myocardial injury through regulating mitochondrial function. European journal of medical research. 25(1). 29–29. 11 indexed citations
16.
Al‐Hendy, Ayman, Andrea S. Lukes, Alfred N. Poindexter, et al.. (2019). Treatment of symptoms of uterine fibroids with relugolix combination therapy: efficacy and safety results from the phase 3 liberty 1 clinical trial. Fertility and Sterility. 112(3). e434–e434. 4 indexed citations
17.
Li, Yulan, et al.. (2013). The Effects of Neuromuscular Blockade on Operating Conditions During General Anesthesia for Spinal Surgery. Journal of Neurosurgical Anesthesiology. 26(1). 45–49. 13 indexed citations
18.
Li, Yulan, et al.. (2010). Perioperative hypothermia and anesthesia management. 31(1). 49–51. 1 indexed citations
19.
Vı́tko, Š, Raimund Margreiter, Willem Weimar, et al.. (2005). Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients. American Journal of Transplantation. 5(10). 2521–2530. 176 indexed citations
20.
Li, Yulan, et al.. (2002). The study on the sensitivity of CdWO 4 scintillating detector for high energy X-ray imaging system. Hedianzixue yu tance jishu. 22(4). 331–334. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026